Reviews Besifloxacin Ophthalmic Suspension


No reviews yet.

Besivance Drug Description
Besivance™
(besifloxacin) Ophthalmic Suspension 0.6% Sterile Topical Ophthalmic Drops
DRUG DESCRIPTION



What are the possible side effects of besifloxacin ophthalmic (Besivance)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:

drainage or crusting of your eye;
severe eye irritation after using the eye drops;
feeling like there is something in your eye;
severe eye redness or swelling; or
fever, or any signs of a new...
Read All Potential Side Effects for Besivance »




Besivance™ (besifloxacin ophthalmic suspension) 0.6%, is a sterile ophthalmic
suspension of besifloxacin formulated with DuraSite®* (polycarbophil, edetate
disodium dihydrate and sodium chloride). Each mL of Besivance™ contains
6.63 mg besifloxacin hydrochloride equivalent to 6 mg besifloxacin base. It
is an 8-chloro fluoroquinolone anti-infective for topical ophthalmic use.








C19H21CIFN3O3•HCI
Mol Wt 430.30
Chemical Name: (+)-7-[(3R)-3-aminohexahydro-1 H-azepin-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-
oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride.
Besifloxacin hydrochloride is a white to pale yellowish-white powder.
Each mL Contains:
Active: besifloxacin 0.6% (6 mg/mL);
Preservative: benzalkonium chloride 0.01%
Inactives: polycarbophil, mannitol, poloxamer 407, sodium chloride,
edetate disodium dihydrate, sodium hydroxide and water for injection.
Besivance™ is an isotonic suspension with an osmolality of approximately 290 mOsm/kg.
Last reviewed on RxList: 6/11/2009




Besivance Drug Description
Besivance™
(besifloxacin) Ophthalmic Suspension 0.6% Sterile Topical Ophthalmic Drops
DRUG DESCRIPTION



What are the possible side effects of besifloxacin ophthalmic (Besivance)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:

drainage or crusting of your eye;
severe eye irritation after using the eye drops;
feeling like there is something in your eye;
severe eye redness or swelling; or
fever, or any signs of a new...
Read All Potential Side Effects for Besivance »




Besivance™ (besifloxacin ophthalmic suspension) 0.6%, is a sterile ophthalmic
suspension of besifloxacin formulated with DuraSite®* (polycarbophil, edetate
disodium dihydrate and sodium chloride). Each mL of Besivance™ contains
6.63 mg besifloxacin hydrochloride equivalent to 6 mg besifloxacin base. It
is an 8-chloro fluoroquinolone anti-infective for topical ophthalmic use.








C19H21CIFN3O3•HCI
Mol Wt 430.30
Chemical Name: (+)-7-[(3R)-3-aminohexahydro-1 H-azepin-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-
oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride.
Besifloxacin hydrochloride is a white to pale yellowish-white powder.
Each mL Contains:
Active: besifloxacin 0.6% (6 mg/mL);
Preservative: benzalkonium chloride 0.01%
Inactives: polycarbophil, mannitol, poloxamer 407, sodium chloride,
edetate disodium dihydrate, sodium hydroxide and water for injection.
Besivance™ is an isotonic suspension with an osmolality of approximately 290 mOsm/kg.
Last reviewed on RxList: 6/11/2009




Besivance Drug Description
Besivance™
(besifloxacin) Ophthalmic Suspension 0.6% Sterile Topical Ophthalmic Drops
DRUG DESCRIPTION



What are the possible side effects of besifloxacin ophthalmic (Besivance)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:

drainage or crusting of your eye;
severe eye irritation after using the eye drops;
feeling like there is something in your eye;
severe eye redness or swelling; or
fever, or any signs of a new...
Read All Potential Side Effects for Besivance »




Besivance™ (besifloxacin ophthalmic suspension) 0.6%, is a sterile ophthalmic
suspension of besifloxacin formulated with DuraSite®* (polycarbophil, edetate
disodium dihydrate and sodium chloride). Each mL of Besivance™ contains
6.63 mg besifloxacin hydrochloride equivalent to 6 mg besifloxacin base. It
is an 8-chloro fluoroquinolone anti-infective for topical ophthalmic use.








C19H21CIFN3O3•HCI
Mol Wt 430.30
Chemical Name: (+)-7-[(3R)-3-aminohexahydro-1 H-azepin-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-
oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride.
Besifloxacin hydrochloride is a white to pale yellowish-white powder.
Each mL Contains:
Active: besifloxacin 0.6% (6 mg/mL);
Preservative: benzalkonium chloride 0.01%
Inactives: polycarbophil, mannitol, poloxamer 407, sodium chloride,
edetate disodium dihydrate, sodium hydroxide and water for injection.
Besivance™ is an isotonic suspension with an osmolality of approximately 290 mOsm/kg.
Last reviewed on RxList: 6/11/2009




Besivance Drug Description
Besivance™
(besifloxacin) Ophthalmic Suspension 0.6% Sterile Topical Ophthalmic Drops
DRUG DESCRIPTION



What are the possible side effects of besifloxacin ophthalmic (Besivance)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:

drainage or crusting of your eye;
severe eye irritation after using the eye drops;
feeling like there is something in your eye;
severe eye redness or swelling; or
fever, or any signs of a new...
Read All Potential Side Effects for Besivance »




Besivance™ (besifloxacin ophthalmic suspension) 0.6%, is a sterile ophthalmic
suspension of besifloxacin formulated with DuraSite®* (polycarbophil, edetate
disodium dihydrate and sodium chloride). Each mL of Besivance™ contains
6.63 mg besifloxacin hydrochloride equivalent to 6 mg besifloxacin base. It
is an 8-chloro fluoroquinolone anti-infective for topical ophthalmic use.








C19H21CIFN3O3•HCI
Mol Wt 430.30
Chemical Name: (+)-7-[(3R)-3-aminohexahydro-1 H-azepin-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-
oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride.
Besifloxacin hydrochloride is a white to pale yellowish-white powder.
Each mL Contains:
Active: besifloxacin 0.6% (6 mg/mL);
Preservative: benzalkonium chloride 0.01%
Inactives: polycarbophil, mannitol, poloxamer 407, sodium chloride,
edetate disodium dihydrate, sodium hydroxide and water for injection.
Besivance™ is an isotonic suspension with an osmolality of approximately 290 mOsm/kg.
Last reviewed on RxList: 6/11/2009




Besivance Drug Description
Besivance™
(besifloxacin) Ophthalmic Suspension 0.6% Sterile Topical Ophthalmic Drops
DRUG DESCRIPTION



What are the possible side effects of besifloxacin ophthalmic (Besivance)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:

drainage or crusting of your eye;
severe eye irritation after using the eye drops;
feeling like there is something in your eye;
severe eye redness or swelling; or
fever, or any signs of a new...
Read All Potential Side Effects for Besivance »




Besivance™ (besifloxacin ophthalmic suspension) 0.6%, is a sterile ophthalmic
suspension of besifloxacin formulated with DuraSite®* (polycarbophil, edetate
disodium dihydrate and sodium chloride). Each mL of Besivance™ contains
6.63 mg besifloxacin hydrochloride equivalent to 6 mg besifloxacin base. It
is an 8-chloro fluoroquinolone anti-infective for topical ophthalmic use.








C19H21CIFN3O3•HCI
Mol Wt 430.30
Chemical Name: (+)-7-[(3R)-3-aminohexahydro-1 H-azepin-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-
oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride.
Besifloxacin hydrochloride is a white to pale yellowish-white powder.
Each mL Contains:
Active: besifloxacin 0.6% (6 mg/mL);
Preservative: benzalkonium chloride 0.01%
Inactives: polycarbophil, mannitol, poloxamer 407, sodium chloride,
edetate disodium dihydrate, sodium hydroxide and water for injection.
Besivance™ is an isotonic suspension with an osmolality of approximately 290 mOsm/kg.
Last reviewed on RxList: 6/11/2009





Other reviews about Besifloxacin Ophthalmic Suspension on wordpress

FDA greenlights Besivance, topical antibacterial for treating bacterial conjunctivitis
  by newsfromaoa
Bausch & Lomb today announced that the U.S. Food and Drug Administration (FDA) approved Besivanceâ„¢ (besifloxacin ophthalmic suspension) 0.6% for the treatment of bacterial conjunctivitis, commonly referred to […]


Besivance Approved for Bacterial Conjunctivitis
  by timeinctemp
FRIDAY, May 29 (HealthDay News) — Besivance (besifloxacin ophthalmic suspension 0.6 percent) has been approved by the U.S. Food and Drug Administration to treat bacterial conjunctivitis, often dubbed […]



Other reviews about Besifloxacin Ophthalmic Suspension on web:

Learn about the prescription medication Besivance (Besifloxacin Ophthalmic Suspension), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Besivance (Besifloxacin Ophthalmic Suspension) Drug Information ...


1. Clin Ther. 2009 Mar;31(3):514-26. Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked ... Besifloxacin ophthalmic suspension 0.6% in patients with bacterial ...


Besivance™ (besifloxacin ophthalmic suspension) 0.6% MATERIAL SAFETY DATA SHEET Effective Date: 4/2/09 Supersedes: None ... Besivance™ (besifloxacin ophthalmic suspension) 0.6%


Tepedino ME, Heller WH, Usner DW, Brunner LS, Morris TW, Haas W, Paterno MR, Comstock TL Phase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the ... Newly Approved Drug Therapies (1028) Besivance (besifloxacin ...


Besivance™ (besifloxacin ophthalmic suspension) 0.6% is a topical ophthalmic antibacterial indicated for the treatment of bacterial conjunctivitis caused by susceptible ... Bausch + Lomb: Besivance™ (besifloxacin ophthalmic suspension) 0.6%


Besifloxacin is a novel fluoroquinolone that, like other fluoroquinolones, acts by inhibiting the essential bacterial enzymes DNA gyrase and topoisomerase IV. Topical besifloxacin ... Besifloxacin Ophthalmic Suspension 0.6% : Drugs


Drug information and side-effects for Besivance (besifloxacin ophthalmic suspension) Besivance (besifloxacin ophthalmic suspension) - Drug information ...


NDA 22-308 Page 5 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Besivance safely and effectively. Besivance (besifloxacin) Ophthalmic Suspension, Bausch


... Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee today voted unanimously to recommend approval of Bausch & Lomb's besifloxacin ophthalmic suspension ... FDA Advisory Committee Recommends Approval of Bausch & Lomb ...


WASHINGTON -- The FDA has approved besifloxacin ophthalmic suspension 0.6% (Besivance) for the treatment of bacterial conjunctivitis. Medical News: FDA Okays Besifloxacin Drops for Conjunctivitis - in ...





Featured Reviews

Reviews Erythromycin Ethylsuccinate

E.E.S. Drug Description E.E.S. 200 Liquid (erythromycin ethylsuccinate for oral suspension) Suspension E.E.S. 400 Liquid (erythromycin ethylsuccinate for oral suspension) Suspension E.E.S. Granules (erythromycin ethylsuccinate...
Read More  |  Review This
Reviews Flovent

Flovent Drug Description FLOVENT® 44 mcg
(fluticasone propionate, 44 mcg) Inhalation Aerosol FLOVENT® 110 mcg (fluticasone propionate, 110 mcg) Inhalation Aerosol FLOVENT® 220 mcg (fluticasone propionate, 220 mcg)...

Read More  |  Review This
Reviews Echothiophate Iodide for Ophthalmic Solution

Phospholine Iodide Drug Description Phospholine Iodide® (echothiophate iodide) for Ophthalmic Solution DRUG DESCRIPTION What are the possible side effects of echothiophate iodide ophthalmic (Phospholine Iodide)? Contact your...
Read More  |  Review This
Reviews Norgestrel And Ethinyl Estradiol

Lo Ovral Drug Description LO/OVRAL®-28 (norgestrel and ethinyl estradiol) Tablets Patients should be counseled that oral contraceptives do not protect against transmission of HIV (AIDS) and other sexually transmitted diseases (STDs)...
Read More  |  Review This
Reviews Streptomycin

Streptomycin Drug Description Streptomycin for Injection USP 1 gram* / vial *Each vial contains Streptomycin Sulfate USP equivalent to 1 gram Streptomycin. For Intramuscular Use To reduce the development of drug-resistant bacteria...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....